Celldex Therapeutics Inc
(NASDAQ:CLDX)
$45.90
At close: Feb 7
$45.90
PreMarket: 4:01PM EDT
Day Range- - -52 Wk Range19.850 - 48.400Open / Close- / -Float / Outstanding40.000M / 47.100M
Vol / Avg.0 / 494.866KMkt Cap2.162BP/E-50d Avg. Price42.740
Div / Yield (Forward)- / -%Payout Ratio-Total Float40.000MEPS-2.260

Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary

Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range19.850 - 48.400Open / Close- / -Float / Outstanding40.000M / 47.100M
Vol / Avg.0 / 494.866KMkt Cap2.162BP/E-50d Avg. Price42.740
Div / Yield (Forward)- / -%Payout Ratio-Total Float40.000MEPS-2.260
TipRanks - Dec 18, 2022, 11:45PM
TipRanks - Jul 21, 2022, 10:15AM
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-04
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A

Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.

Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary

Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range19.850 - 48.400Open / Close- / -Float / Outstanding40.000M / 47.100M
Vol / Avg.0 / 494.866KMkt Cap2.162BP/E-50d Avg. Price42.740
Div / Yield (Forward)- / -%Payout Ratio-Total Float40.000MEPS-2.260
TipRanks - Dec 18, 2022, 11:45PM
TipRanks - Jul 21, 2022, 10:15AM
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-04
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A

Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.

Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary

Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range19.850 - 48.400Open / Close- / -Float / Outstanding40.000M / 47.100M
Vol / Avg.0 / 494.866KMkt Cap2.162BP/E-50d Avg. Price42.740
Div / Yield (Forward)- / -%Payout Ratio-Total Float40.000MEPS-2.260
TipRanks - Dec 18, 2022, 11:45PM
TipRanks - Jul 21, 2022, 10:15AM
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-04
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A

Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.

Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary

Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range19.850 - 48.400Open / Close- / -Float / Outstanding40.000M / 47.100M
Vol / Avg.0 / 494.866KMkt Cap2.162BP/E-50d Avg. Price42.740
Div / Yield (Forward)- / -%Payout Ratio-Total Float40.000MEPS-2.260
TipRanks - Dec 18, 2022, 11:45PM
TipRanks - Jul 21, 2022, 10:15AM
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-04
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A

Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.

Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary

Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range19.850 - 48.400Open / Close- / -Float / Outstanding40.000M / 47.100M
Vol / Avg.0 / 494.866KMkt Cap2.162BP/E-50d Avg. Price42.740
Div / Yield (Forward)- / -%Payout Ratio-Total Float40.000MEPS-2.260
TipRanks - Dec 18, 2022, 11:45PM
TipRanks - Jul 21, 2022, 10:15AM
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-04
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A

Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.

Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary

Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range19.850 - 48.400Open / Close- / -Float / Outstanding40.000M / 47.100M
Vol / Avg.0 / 494.866KMkt Cap2.162BP/E-50d Avg. Price42.740
Div / Yield (Forward)- / -%Payout Ratio-Total Float40.000MEPS-2.260
TipRanks - Dec 18, 2022, 11:45PM
TipRanks - Jul 21, 2022, 10:15AM
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-04
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A

Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.

Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary

Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range19.850 - 48.400Open / Close- / -Float / Outstanding40.000M / 47.100M
Vol / Avg.0 / 494.866KMkt Cap2.162BP/E-50d Avg. Price42.740
Div / Yield (Forward)- / -%Payout Ratio-Total Float40.000MEPS-2.260
TipRanks - Dec 18, 2022, 11:45PM
TipRanks - Jul 21, 2022, 10:15AM
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-04
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A

Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.

Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary

Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range19.850 - 48.400Open / Close- / -Float / Outstanding40.000M / 47.100M
Vol / Avg.0 / 494.866KMkt Cap2.162BP/E-50d Avg. Price42.740
Div / Yield (Forward)- / -%Payout Ratio-Total Float40.000MEPS-2.260
TipRanks - Dec 18, 2022, 11:45PM
TipRanks - Jul 21, 2022, 10:15AM
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-04
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A

Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.

Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary

Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range19.850 - 48.400Open / Close- / -Float / Outstanding40.000M / 47.100M
Vol / Avg.0 / 494.866KMkt Cap2.162BP/E-50d Avg. Price42.740
Div / Yield (Forward)- / -%Payout Ratio-Total Float40.000MEPS-2.260
TipRanks - Dec 18, 2022, 11:45PM
TipRanks - Jul 21, 2022, 10:15AM
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-04
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 37.25% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $45.9 last updated February 7, 2023 at 9:00 PM UTC.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A

Celldex Therapeutics’s Q1 earnings are confirmed for Thursday, May 4, 2023.

Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.